First treatment against liver scarring caused by a type of ‘fatty liver disease’

View source ↗

Summary

EMA approved the first treatment for liver scarring caused by a fatty liver disease. The drug is indicated for adults with moderate to advanced fibrosis due to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• REZDIFFRA (RESMETIROM)

Snippet

Rezdiffra is indicated for patients with moderate to advanced scarring due to accumulation of fat